Lung/Bronchial NETs

PRRT Trials

• Alpha PRRT with Pb212 (all NET)

• Lu177 DOTATATE + Cabozantanib (all NET)

• Lu-177 DOTATATE vs Everolimus in Lung NETs

Other Trials

• Surviving Long Peptide Vaccine (SurVaxM) in Metastatic NETs